Two cancer drug trials put on hold after patients died, companies say | CNN

The two trials were unrelated: They were in different stages and testing therapies. But both were testing new cancer treatments. One was testing a treatment for a blood cancer called acute myeloid leukemia, or AML, and the other was testing a new agent for ovarian cancer. Deaths in clinical trials are thought to be rare.

“The safety of every patient who participates in our studies or is treated with our therapies is the utmost priority for us, and we are in communication with FDA while we assess the data surrounding this SAE [serious adverse event], and the potential next steps for the study,” said Dr. Steve Bernstein, chief medical officer 2seventy bio, in a news release. The second study, on ovarian cancer, was in phase three – typically the final stage before a company presents a drug for FDA approval.

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Sam Bankman-Fried's trial to be split up as attorneys challenge some counts | CNN BusinessFTX founder Sam Bankman-Fried will have his criminal trial split into two separate proceedings, a judge ruled Thursday, granting a request from prosecutors who worried that five of the 13 charges could be held up by a Bahamian court’s review.
Herkunft: CNN - 🏆 4. / 95 Weiterlesen »